Clinical outcome of recurrent giant cell tumor of the extremity in the era before molecular target therapy: the Japanese Musculoskeletal Oncology Group study.

BMC Musculoskelet Disord · 2016 · PMC4957292 · PMID 27448567

Europe PMC DOI

hedged sentence

0.0590

closest p · 1.2× alpha

0.0590

boldest claim

The sentences

only marginally significantP = 0.059so close (0.05 < p ≤ 0.1)

Campanacci Grade III was significantly correlated with sacrifice of the adjacent joint by univariate statistical analysis ( P = 0.019), although its impact was only marginally significant by multivariate analysis ( P = 0.059).

also in 5,076 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.